Analytical Data
-
Gene name
AFUA_4G09580
- Application
-
Alternative Names
Allergen Asp f II Allergen: Asp f 2
-
Species
Neosartorya fumigata
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P79017
-
Expression Region
17-310aa
-
Molecular Weight
47.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AFUA_4G09580 is a gene located in the filamentous fungus Aspergillus fumigatus, a significant human pathogen known for causing severe respiratory infections, particularly in immunocompromised individuals. The study of AFUA_4G09580 is driven by the need to understand its functional role in the biology of A. fumigatus, particularly in the context of its pathogenicity, stress response, and adaptation to hostile environments. Investigating the recombinant protein it encodes can provide insights into the mechanisms by which this fungus evades host defenses and establishes infection. Furthermore, understanding the structure and function of the AFUA_4G09580 protein may reveal novel therapeutic targets, as current antifungal treatments are limited and often result in resistance. The identification of unique aspects of this protein could lead to the development of innovative antifungal strategies. Overall, research on AFUA_4G09580 is pivotal not only for advancing our knowledge of A. fumigatus biology but also for addressing the growing challenge of antifungal resistance in clinical settings.
